Carson Wealth (CWM LLC)’s Cogent Biosciences COGT Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$269K	Buy	6,990 +1,132	+19%	+$41.8K	﹤0.01%	2471
2025 Q4	$208K	Buy	5,858 +276	+5%	+$7.76K	﹤0.01%	2542
2025 Q3	$80K	Buy	5,582 +1,126	+25%	+$13.3K	﹤0.01%	3152
2025 Q2	$32K	Sell	4,456 -4,282	-49%	-$23.7K	﹤0.01%	3606
2025 Q1	$52K	Buy	8,738 +8,665	+11,870%	+$67.9K	﹤0.01%	2952
2024 Q4	$1K	Buy	73 +6	+9%	+$60	﹤0.01%	4677
2024 Q3	$1K	Buy	67 +52	+347%	+$506	﹤0.01%	4539
2024 Q2	$0	Buy	+15	New	+$114	﹤0.01%	4627
2022 Q2	–	Sell	-129	Closed	-$1K	–	3822
2022 Q1	$1K	Buy	+129	New	+$898	﹤0.01%	3314

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Carson Wealth (CWM LLC)'s COGT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Cogent Biosciences (COGT) stake by 19% in Q1 2026, buying an estimated $41.8K and bringing the position to 6,990 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #2471.

Carson Wealth (CWM LLC) first reported a position in COGT in Q1 2022 and has held it in 9 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

Carson Wealth (CWM LLC) held 6,990 shares of Cogent Biosciences worth $269K as of Q1 2026.
Carson Wealth (CWM LLC) bought 1,132 Cogent Biosciences shares in Q1 2026, an estimated $41.8K.
Cogent Biosciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2471 holding.
Carson Wealth (CWM LLC) first reported a position in Cogent Biosciences in Q1 2022 and has held it in 9 quarters since.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.